Analyst Price Target is $2.75
▲ +357.57% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Forte Biosciences in the last 3 months. The average price target is $2.75, with a high forecast of $2.75 and a low forecast of $2.75. The average price target represents a 357.57% upside from the last price of $0.60.
Current Consensus is
Moderate Buy
The current consensus among 2 contributing investment analysts is to moderate buy stock in Forte Biosciences. This Moderate Buy consensus rating has held steady for over two years.